JASON ELY: Open Payments
NPI 1104595396 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$206 in 12 payments from 7 companies in 2025. Trend: 2023 $277 · 2024 $280 · 2025 $206
Food & beverage: $206
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Lilly USA, LLC | 3 | $49 |
| Renalytix AI, Inc. | 2 | $34 |
| Lundbeck LLC | 1 | $22 |
| Novo Nordisk Inc | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| ABBVIE INC. | 1 | $14 |
Products named: MOUNJARO, FARXIGA, KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT, REXULTI, Wegovy, BREZTRI, CAPLYTA, VRAYLAR.
Industry payments across MS — which companies pay providers there.
